Rock Springs Capital Management LP / BMRN
Rock Springs Capital Management LP’s Biomarin Pharmaceutical Inc Position
Does Rock Springs Capital Management LP own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 151.0K shares worth $11M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$11M
Q3 2024
Shares
151.0K
% of Portfolio
+0.35%
Quarters Held
24
position exited
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 151.0K | $11M | +0.35% |
| Q2 2024 | 151.0K | $12M | +0.37% |
| Q1 2024 | 148.8K | $13M | +0.33% |
| Q4 2023 | 148.8K | $14M | +0.35% |
| Q3 2023 | 264.5K | $23M | +0.63% |
| Q2 2023 | 264.5K | $23M | +0.55% |
| Q1 2023 | 264.5K | $26M | +0.61% |
| Q4 2022 | 264.5K | $27M | +0.66% |
| Q3 2022 | 264.5K | $22M | +0.58% |
| Q2 2022 | 264.5K | $22M | +0.64% |
| Q1 2022 | 264.5K | $20M | +0.51% |
| Q4 2021 | 264.0K | $23M | +0.54% |
| Q3 2021 | 253.5K | $20M | +0.41% |
| Q2 2021 | 253.5K | $21M | +0.42% |
| Q1 2021 | 253.5K | $19M | +0.42% |
| Q4 2020 | 253.5K | $22M | +0.47% |
| Q3 2020 | 350.0K | $27M | +0.68% |
| Q2 2020 | 387.5K | $48M | +1.31% |
| Q1 2020 | 380.0K | $32M | +1.33% |
| Q4 2019 | 337.5K | $29M | +0.90% |
| Q3 2019 | 142.5K | $10M | +0.38% |
| Q2 2019 | 142.5K | $12M | +0.44% |
| Q1 2019 | 135.0K | $12M | +0.46% |
| Q4 2018 | 129.0K | $11M | +0.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of BMRN.